相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Viktor Soukup et al.
EUROPEAN UROLOGY (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism
Kunitoshi Chiba et al.
SCIENCE (2017)
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
Francoise Descotes et al.
BRITISH JOURNAL OF CANCER (2017)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: A retrospective cohort study
Pedro Castelo-Branco et al.
ONCOTARGET (2016)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
Ismail Hosen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TERT promoter mutations and telomerase reactivation in urothelial cancer
Sumit Borah et al.
SCIENCE (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study
Song Wu et al.
EUROPEAN UROLOGY (2014)
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
Yves Allory et al.
EUROPEAN UROLOGY (2014)
Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine
Carolyn D. Hurst et al.
EUROPEAN UROLOGY (2014)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack et al.
NATURE (2014)
Regional Activation of the Cancer Genome by Long-Range Epigenetic Remodeling
Saul A. Bert et al.
CANCER CELL (2013)
TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
Isaac Kinde et al.
CANCER RESEARCH (2013)
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco et al.
LANCET ONCOLOGY (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene
S. Renaud et al.
NUCLEIC ACIDS RESEARCH (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas
Uri Tabori et al.
NEOPLASIA (2006)